Clinical Management of Vertebral Compression Fractures.

[1]  Nicholas Harvey,et al.  The Osteoporosis Treatment Gap , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  M. Reiser,et al.  Quantitative evaluation of benign and malignant vertebral fractures with diffusion-weighted MRI: what is the optimum combination of b values for ADC-based lesion differentiation with the single-shot turbo spin-echo sequence? , 2014, AJR. American journal of roentgenology.

[3]  K. Schenck-Gustafsson,et al.  EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture. , 2014, Maturitas.

[4]  J. M. Harris,et al.  PINP as a biological response marker during teriparatide treatment for osteoporosis , 2014, Osteoporosis International.

[5]  S. Silverman,et al.  The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group , 2014, Osteoporosis International.

[6]  E. M. Lewiecki,et al.  Clinician’s Guide to Prevention and Treatment of Osteoporosis , 2014, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

[7]  M. Gourlay,et al.  Salmon Calcitonin Use and Associated Cancer Risk , 2013, The Annals of pharmacotherapy.

[8]  J. Schousboe,et al.  The Official Positions of the International Society for Clinical Densitometry: vertebral fracture assessment. , 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[9]  C. Rossi,et al.  Atraumatic vertebral compression fractures: differential diagnosis between benign osteoporotic and malignant fractures by MRI , 2013, MUSCULOSKELETAL SURGERY.

[10]  A. El Maghraoui,et al.  Systematic vertebral fracture assessment in asymptomatic postmenopausal women. , 2013, Bone.

[11]  D. Bauer,et al.  Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. , 2013, The American journal of medicine.

[12]  P. Miller.  Unrecognized and unappreciated secondary causes of osteoporosis. , 2012, Endocrinology and metabolism clinics of North America.

[13]  J. Macho,et al.  Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: A 12‐month randomized follow‐up, controlled trial , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  R. Recker,et al.  Benefits and risks of bisphosphonate therapy for osteoporosis. , 2012, The Journal of clinical endocrinology and metabolism.

[15]  J. Eisman,et al.  RESEARCH ARTICLE Open Access Prevalence of vertebral fractures in women and men in the population-based Tromsø Study , 2022 .

[16]  David A Hanley,et al.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary , 2010, Canadian Medical Association Journal.

[17]  N. Watts,et al.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[18]  G. Dinant,et al.  Timing of Subsequent Fractures after an Initial Fracture , 2010, Current osteoporosis reports.

[19]  Paolo Vitti,et al.  American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[20]  Claus Christiansen,et al.  Denosumab for prevention of fractures in postmenopausal women with osteoporosis. , 2009, The New England journal of medicine.

[21]  E. Buskens,et al.  Nonoperative Treatment of Thoracic and Lumbar Spine Fractures: A Prospective Randomized Study of Different Treatment Options , 2009, Journal of orthopaedic trauma.

[22]  R. Civitelli,et al.  Bone turnover markers: understanding their value in clinical trials and clinical practice , 2009, Osteoporosis International.

[23]  T. Gross,et al.  Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: a population-based cohort study , 2009, Osteoporosis International.

[24]  Martha Timmer,et al.  Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis , 2007, Annals of Internal Medicine.

[25]  S. Cummings,et al.  Long-term risk of incident vertebral fractures. , 2007, JAMA.

[26]  P. Miller.  Guidelines for the diagnosis of osteoporosis: T-scores vs fractures , 2007, Reviews in Endocrine and Metabolic Disorders.

[27]  E. Lewiecki,et al.  Clinical review: Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. , 2006, The Journal of clinical endocrinology and metabolism.

[28]  K. Ensrud,et al.  Association Between Prior Non‐Spine Non‐Hip Fractures or Prevalent Radiographic Vertebral Deformities Known to be at Least 10 Years Old and Incident Hip Fracture , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  L. Ferrar,et al.  Vertebral fracture assessment: the 2005 ISCD Official Positions. , 2006, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[30]  A. Silman,et al.  The epidemiology of vertebral fractures , 2006, Osteoporosis International.

[31]  K. Siminoski,et al.  The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal women , 2006, Osteoporosis International.

[32]  D. Kiel,et al.  Reduced risk of back pain following teriparatide treatment: a meta-analysis , 2006, Osteoporosis International.

[33]  P. Miller.  Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction , 2005, Current osteoporosis reports.

[34]  J. Cauley,et al.  What Proportion of Incident Radiographic Vertebral Deformities Is Clinically Diagnosed and Vice Versa? , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  Ian Colman,et al.  Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients. , 2005, Archives of internal medicine.

[36]  H. Genant,et al.  Underdiagnosis of Vertebral Fractures Is a Worldwide Problem: The IMPACT Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  T. Spector,et al.  The assessment of vertebral deformity: A method for use in population studies and clinical trials , 1993, Osteoporosis International.

[38]  C. Cooper,et al.  Prevalence and incidence of vertebral deformities , 1993, Osteoporosis International.

[39]  R. Eastell,et al.  Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures , 2005, Osteoporosis International.

[40]  H. Minne,et al.  Effects of a New Spinal Orthosis on Posture, Trunk Strength, and Quality of Life in Women with Postmenopausal Osteoporosis: A Randomized Trial , 2004, American journal of physical medicine & rehabilitation.

[41]  O. Johnell,et al.  Fracture risk following an osteoporotic fracture , 2004, Osteoporosis International.

[42]  H. Genant,et al.  Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. , 2003, Bone.

[43]  G. Lyritis,et al.  Analgesic effects of calcitonin. , 2002, Bone.

[44]  R. Parker,et al.  Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis. , 2001, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[45]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[46]  P Geusens,et al.  Risk of new vertebral fracture in the year following a fracture. , 2001, JAMA.

[47]  D. Kiel,et al.  A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. , 2000, The American journal of medicine.

[48]  S. A. Jackson,et al.  Vertebral Fracture Definition from Population-Based Data: Preliminary Results from the Canadian Multicenter Osteoporosis Study (CaMos) , 2000, Osteoporosis International.

[49]  M. Hooper,et al.  Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis , 2000, Osteoporosis International.

[50]  H K Genant,et al.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. , 1999, JAMA.

[51]  C C Glüer,et al.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. , 1999, JAMA.

[52]  J Pearson,et al.  Prevalent Vertebral Deformities Predict Hip Fractures and New Vertebral Deformities but Not Wrist Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[53]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[54]  A. Silman,et al.  The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group. , 1993, Bone.

[55]  L. M. Singhvi.  Freedom on trial , 1991 .